These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 23188490

  • 1. Validation of the menstrual pictogram in women with leiomyomata associated with heavy menstrual bleeding.
    Larsen L, Coyne K, Chwalisz K.
    Reprod Sci; 2013 Jun; 20(6):680-7. PubMed ID: 23188490
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of the selective progesterone receptor modulator asoprisnil on uterine artery blood flow, ovarian activity, and clinical symptoms in patients with uterine leiomyomata scheduled for hysterectomy.
    Wilkens J, Chwalisz K, Han C, Walker J, Cameron IT, Ingamells S, Lawrence AC, Lumsden MA, Hapangama D, Williams AR, Critchley HO.
    J Clin Endocrinol Metab; 2008 Dec; 93(12):4664-71. PubMed ID: 18765509
    [Abstract] [Full Text] [Related]

  • 7. Validation of a new menstrual pictogram (superabsorbent polymer-c version) for use with ultraslim towels that contain superabsorbent polymers.
    Magnay JL, Nevatte TM, O'Brien S, Gerlinger C, Seitz C.
    Fertil Steril; 2014 Feb; 101(2):515-22. PubMed ID: 24331833
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata.
    Chwalisz K, Larsen L, Mattia-Goldberg C, Edmonds A, Elger W, Winkel CA.
    Fertil Steril; 2007 Jun; 87(6):1399-412. PubMed ID: 17307170
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Naproxen reduces idiopathic but not fibromyoma-induced menorrhagia.
    Ylikorkala O, Pekonen F.
    Obstet Gynecol; 1986 Jul; 68(1):10-2. PubMed ID: 3523328
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Measured menstrual blood loss in women with menorrhagia associated with pelvic disease or coagulation disorder.
    Fraser IS, McCarron G, Markham R, Resta T, Watts A.
    Obstet Gynecol; 1986 Nov; 68(5):630-3. PubMed ID: 3763074
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Elagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.
    Carr BR, Stewart EA, Archer DF, Al-Hendy A, Bradley L, Watts NB, Diamond MP, Gao J, Owens CD, Chwalisz K, Duan WR, Soliman AM, Dufek MB, Simon JA.
    Obstet Gynecol; 2018 Nov; 132(5):1252-1264. PubMed ID: 30303923
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.